265 related articles for article (PubMed ID: 26971998)
1. The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.
Koblansky AA; Truax AD; Liu R; Montgomery SA; Ding S; Wilson JE; Brickey WJ; Mühlbauer M; McFadden RM; Hu P; Li Z; Jobin C; Lund PK; Ting JP
Cell Rep; 2016 Mar; 14(11):2562-75. PubMed ID: 26971998
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
3. NLRX1 Acts as an Epithelial-Intrinsic Tumor Suppressor through the Modulation of TNF-Mediated Proliferation.
Tattoli I; Killackey SA; Foerster EG; Molinaro R; Maisonneuve C; Rahman MA; Winer S; Winer DA; Streutker CJ; Philpott DJ; Girardin SE
Cell Rep; 2016 Mar; 14(11):2576-86. PubMed ID: 26971996
[TBL] [Abstract][Full Text] [Related]
4. Flavonoids Extracted from Licorice Prevents Colitis-Associated Carcinogenesis in AOM/DSS Mouse Model.
Huo X; Liu D; Gao L; Li L; Cao L
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563884
[TBL] [Abstract][Full Text] [Related]
5. Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6/STAT3 signaling pathway.
Yang X; Zhang F; Wang Y; Cai M; Wang Q; Guo Q; Li Z; Hu R
Inflamm Bowel Dis; 2013 Aug; 19(9):1990-2000. PubMed ID: 23823704
[TBL] [Abstract][Full Text] [Related]
6. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway.
Zheng R; Ma J; Wang D; Dong W; Wang S; Liu T; Xie R; Liu L; Wang B; Cao H
Mediators Inflamm; 2018; 2018():1562010. PubMed ID: 30498394
[TBL] [Abstract][Full Text] [Related]
8. Rosmarinic acid represses colitis-associated colon cancer: A pivotal involvement of the TLR4-mediated NF-κB-STAT3 axis.
Jin BR; Chung KS; Hwang S; Hwang SN; Rhee KJ; Lee M; An HJ
Neoplasia; 2021 Jun; 23(6):561-573. PubMed ID: 34077834
[TBL] [Abstract][Full Text] [Related]
9. The mitochondrial protein NLRX1 controls the balance between extrinsic and intrinsic apoptosis.
Soares F; Tattoli I; Rahman MA; Robertson SJ; Belcheva A; Liu D; Streutker C; Winer S; Winer DA; Martin A; Philpott DJ; Arnoult D; Girardin SE
J Biol Chem; 2014 Jul; 289(28):19317-30. PubMed ID: 24867956
[TBL] [Abstract][Full Text] [Related]
10. NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-κB signaling.
Coutermarsh-Ott S; Simmons A; Capria V; LeRoith T; Wilson JE; Heid B; Philipson CW; Qin Q; Hontecillas-Magarzo R; Bassaganya-Riera J; Ting JP; Dervisis N; Allen IC
Oncotarget; 2016 May; 7(22):33096-110. PubMed ID: 27105514
[TBL] [Abstract][Full Text] [Related]
11. 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.
Mao F; Xu M; Zuo X; Yu J; Xu W; Moussalli MJ; Elias E; Li HS; Watowich SS; Shureiqi I
FASEB J; 2015 Jun; 29(6):2359-70. PubMed ID: 25713055
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK
Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444
[TBL] [Abstract][Full Text] [Related]
13. Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice.
Hayashi S; Hamada T; Zaidi SF; Oshiro M; Lee J; Yamamoto T; Ishii Y; Sasahara M; Kadowaki M
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G968-78. PubMed ID: 25258409
[TBL] [Abstract][Full Text] [Related]
14. Targeted deletion of miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer.
Zou F; Mao R; Yang L; Lin S; Lei K; Zheng Y; Ding Y; Zhang P; Cai G; Liang X; Liu J
FEBS J; 2016 Apr; 283(8):1438-52. PubMed ID: 26859226
[TBL] [Abstract][Full Text] [Related]
15. PDCD4 Deficiency Aggravated Colitis and Colitis-associated Colorectal Cancer Via Promoting IL-6/STAT3 Pathway in Mice.
Wang L; Zhao M; Guo C; Wang G; Zhu F; Wang J; Wang X; Wang Q; Zhao W; Shi Y; Chen YH; Zhang L
Inflamm Bowel Dis; 2016 May; 22(5):1107-18. PubMed ID: 26891257
[TBL] [Abstract][Full Text] [Related]
16. Anti-Obesity Drug Orlistat Alleviates Western-Diet-Driven Colitis-Associated Colon Cancer via Inhibition of STAT3 and NF-κB-Mediated Signaling.
Jin BR; Kim HJ; Sim SA; Lee M; An HJ
Cells; 2021 Aug; 10(8):. PubMed ID: 34440829
[TBL] [Abstract][Full Text] [Related]
17. Wu Mei Wan attenuates CAC by regulating gut microbiota and the NF-kB/IL6-STAT3 signaling pathway.
Jiang F; Liu M; Wang H; Shi G; Chen B; Chen T; Yuan X; Zhu P; Zhou J; Wang Q; Chen Y
Biomed Pharmacother; 2020 May; 125():109982. PubMed ID: 32119646
[TBL] [Abstract][Full Text] [Related]
18. Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice.
Li TW; Yang H; Peng H; Xia M; Mato JM; Lu SC
Carcinogenesis; 2012 Feb; 33(2):427-35. PubMed ID: 22159228
[TBL] [Abstract][Full Text] [Related]
19. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
[TBL] [Abstract][Full Text] [Related]
20. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
